QuantaFlo HD Clinical Validation Study
Recruiting
Observational Study
To Assess Cardiovascular Function
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 22 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 600 (estimated)
- Sponsor
- Semler Scientific · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The primary aim of this validation protocol is to assess cardiovascular function through transthoracic echocardiography ("Echo") measurements and the QuantaFlo HD test measuring blood flow at the finger during a forced expiration ("FE"). The study examines whether Echo-measured GLS values greater than -16% correlate with abnormal responses during FE as measured by QuantaFlo HD.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Male and female adult (≥ age 22) subjects with a minimum of 1 of the following:
* A history of Cardiovascular Diseasei or PAD
* Recorded history of at least two of the following
* Hypertension
* Diabetes
* Hyperlipidemia
Exclusion Criteria:
* Unable to safely perform a force…
Contacts